Cargando…
SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database
The coronavirus disease 19 (COVID-19) is a highly pathogenic viral infection of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in the global pandemic of 2020. A lack of therapeutic and preventive strategies has quickly posed significant threats to world health. A co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124966/ https://www.ncbi.nlm.nih.gov/pubmed/37101659 http://dx.doi.org/10.1093/nargab/lqad037 |
_version_ | 1785029939516407808 |
---|---|
author | Rahimian, Karim Arefian, Ehsan Mahdavi, Bahar Mahmanzar, Mohammadamin Kuehu, Donna Lee Deng, Youping |
author_facet | Rahimian, Karim Arefian, Ehsan Mahdavi, Bahar Mahmanzar, Mohammadamin Kuehu, Donna Lee Deng, Youping |
author_sort | Rahimian, Karim |
collection | PubMed |
description | The coronavirus disease 19 (COVID-19) is a highly pathogenic viral infection of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in the global pandemic of 2020. A lack of therapeutic and preventive strategies has quickly posed significant threats to world health. A comprehensive understanding of SARS-CoV-2 evolution and natural selection, how it impacts host interaction, and phenotype symptoms is vital to develop effective strategies against the virus. The SARS2Mutant database (http://sars2mutant.com/) was developed to provide valuable insights based on millions of high-quality, high-coverage SARS-CoV-2 complete protein sequences. Users of this database have the ability to search for information on three amino acid substitution mutation strategies based on gene name, geographical zone, or comparative analysis. Each strategy is presented in five distinct formats which includes: (i) mutated sample frequencies, (ii) heat maps of mutated amino acid positions, (iii) mutation survivals, (iv) natural selections and (v) details of substituted amino acids, including their names, positions, and frequencies. GISAID is a primary database of genomics sequencies of influenza viruses updated daily. SARS2Mutant is a secondary database developed to discover mutation and conserved regions from the primary data to assist with design for targeted vaccine, primer, and drug discoveries. |
format | Online Article Text |
id | pubmed-10124966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101249662023-04-25 SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database Rahimian, Karim Arefian, Ehsan Mahdavi, Bahar Mahmanzar, Mohammadamin Kuehu, Donna Lee Deng, Youping NAR Genom Bioinform Standard Article The coronavirus disease 19 (COVID-19) is a highly pathogenic viral infection of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in the global pandemic of 2020. A lack of therapeutic and preventive strategies has quickly posed significant threats to world health. A comprehensive understanding of SARS-CoV-2 evolution and natural selection, how it impacts host interaction, and phenotype symptoms is vital to develop effective strategies against the virus. The SARS2Mutant database (http://sars2mutant.com/) was developed to provide valuable insights based on millions of high-quality, high-coverage SARS-CoV-2 complete protein sequences. Users of this database have the ability to search for information on three amino acid substitution mutation strategies based on gene name, geographical zone, or comparative analysis. Each strategy is presented in five distinct formats which includes: (i) mutated sample frequencies, (ii) heat maps of mutated amino acid positions, (iii) mutation survivals, (iv) natural selections and (v) details of substituted amino acids, including their names, positions, and frequencies. GISAID is a primary database of genomics sequencies of influenza viruses updated daily. SARS2Mutant is a secondary database developed to discover mutation and conserved regions from the primary data to assist with design for targeted vaccine, primer, and drug discoveries. Oxford University Press 2023-04-24 /pmc/articles/PMC10124966/ /pubmed/37101659 http://dx.doi.org/10.1093/nargab/lqad037 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Standard Article Rahimian, Karim Arefian, Ehsan Mahdavi, Bahar Mahmanzar, Mohammadamin Kuehu, Donna Lee Deng, Youping SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title | SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title_full | SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title_fullStr | SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title_full_unstemmed | SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title_short | SARS2Mutant: SARS-CoV-2 amino-acid mutation atlas database |
title_sort | sars2mutant: sars-cov-2 amino-acid mutation atlas database |
topic | Standard Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124966/ https://www.ncbi.nlm.nih.gov/pubmed/37101659 http://dx.doi.org/10.1093/nargab/lqad037 |
work_keys_str_mv | AT rahimiankarim sars2mutantsarscov2aminoacidmutationatlasdatabase AT arefianehsan sars2mutantsarscov2aminoacidmutationatlasdatabase AT mahdavibahar sars2mutantsarscov2aminoacidmutationatlasdatabase AT mahmanzarmohammadamin sars2mutantsarscov2aminoacidmutationatlasdatabase AT kuehudonnalee sars2mutantsarscov2aminoacidmutationatlasdatabase AT dengyouping sars2mutantsarscov2aminoacidmutationatlasdatabase |